Tipping Point Biosciences

TippingPoint

TippingPoint Biosciences develops a drug discovery platform targeting disease-specific chromatin states to create therapies for cancers and other genome packaging disorders.

Dewpoint Therapeutics

This biotechnology company develops condensate-modifying small molecule drugs for patients with oncology, neurodegenerative, cardiopulmonary and metabolic diseases using an AI-enabled discovery platform.

Plexium

This company develops targeted protein degradation therapeutics and discovery platforms for patients with cancer and neurodegenerative diseases.

Rodin Therapeutics

This biotechnology company develops small molecule therapies targeting epigenetic mechanisms to treat neurodegenerative and cognitive disorders for patients with diseases like Alzheimer's.

D3 Bio

This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.

Ribon Therapeutics

This biotechnology company develops small molecule inhibitors targeting stress support pathways for patients with cancer and inflammatory diseases.

Trimtech Therapeutics

This biotechnology company develops small molecule drugs that target and degrade toxic protein aggregates to treat neurodegenerative and inflammatory diseases.

Fore Bio

This biotechnology company develops precision oncology therapies and small-molecule inhibitors for patients with unaddressed tumour mutations and hard-to-treat cancers.